Knoxville, Tenn.-based ChoiceSpine is partnering with France-based eCential Robotics to combine their technologies into one system.
ChoiceSpine's implants include minimally invasive and orthobiologic products, according to a June 21 news release. ECential Robotics' platform combines intraoperative 2D and 3D imaging and navigation in a fully-unified single-device system. ECential Robotics' technology is FDA-cleared, and preclinical evaluation tests have been conducted in the U.S. in 2022.
"This combination of our innovative cultures will allow us to expand our clinical value by fully encompassing the surgical experience," Steve Ainsworth, PhD, executive vice president of strategy and technology at ChoiceSpine, said in the release. "We believe the eCential Robotics platform, in conjunction with our comprehensive spinal implant and orthobiologics portfolios, will lead the way in advancing spine surgery."